Meeting
2015 Genitourinary Cancers Symposium
Effect of lipid nanoparticle siRNA delivery systems on silencing clusterin and progression in enzalutamide resistant prostate cancer in vivo.
Authors
Yoshiaki Yamamoto
The Vancouver Prostate Centre and Department of Urologic Sciences, Vancouver, BC, Canada
Yoshiaki Yamamoto , Paulo JC Lin , Fan Zhang , Yoshihisa Kawai , Eliana Beraldi , Jeffrey Leong , Hideyasu Matsuyama , Pieter R Cullis , Martin Edwin Gleave
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 256)
DOI
10.1200/jco.2015.33.7_suppl.256
Abstract #
256
Poster Bd #
C25
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer.
First Author: Taavi Neklesa
Poster
2018 Genitourinary Cancers Symposium
An oral androgen receptor PROTAC degrader for prostate cancer.
First Author: Taavi Neklesa
Poster
2017 Genitourinary Cancers Symposium
The impact of TAS3681, a new type of androgen receptor antagonist, on aberrant AR signaling that drives tumor resistance to AR-targeted therapies by down-regulating full length and splice variant AR.
First Author: Daisuke Kajiwara
Poster
2017 Genitourinary Cancers Symposium
An oral androgen receptor PROTAC degrader for prostate cancer.
First Author: Taavi K Neklesa